Annovis Bio (ANVS) is down -25.6%, or -$1.25 to $3.62.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio announces pricing of $21M offering of stock, warrants
- Annovis Bio granted U.S. patent covering buntanetap
- Annovis Bio announces FDA acceptance of protocol for Phase 3 AD study
- Annovis Bio Advances Alzheimer’s and Parkinson’s Drug Trials
- Annovis Bio Appoints William Fricker as Interim CFO